Stocktoria
Sonova Holding AG SOON.SW
CH · SIX Swiss Exchange · XSWX · stock · Healthcare · website
Sonova Holding AG financials (annual, from 10-K)
Bars are annual figures from 2023 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | $3.6B | $3.6B | $3.6B | $3.7B |
| Gross profit | $2.7B | $2.7B | $2.6B | $2.6B |
| R&D expense | $217.7M | $214.3M | $239.0M | $244.6M |
| SG&A expense | $1.7B | $1.8B | $1.7B | $1.6B |
| Operating income | $675.9M | $719.8M | $669.9M | $746.8M |
| Interest expense | $28.7M | $26.9M | $28.2M | $23.4M |
| Income tax | $95.7M | $119.4M | $37.8M | $57.4M |
| Net income | $430.6M | $540.5M | $601.0M | $647.5M |
| EPS (diluted) | $7.22 | $9.04 | $10.05 | $10.72 |
| Operating cash flow | $734.5M | $790.3M | $753.3M | $783.9M |
| Free cash flow | $631.8M | $658.6M | $624.7M | $629.6M |
| Cash & equivalents | $722.0M | $686.9M | $513.6M | $413.9M |
| Inventory | $381.0M | $468.5M | $435.6M | $419.1M |
| Total assets | $5.6B | $5.9B | $5.8B | $5.6B |
| Total liabilities | $3.0B | $3.2B | $3.3B | $3.3B |
| Shareholders' equity | $2.6B | $2.7B | $2.5B | $2.2B |
Growth · year-over-year · Revenue CAGR -1.2%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue growth | -0.2% | -0.4% | -3.0% | — |
| Net income growth | -20.3% | -10.1% | -7.2% | — |
| EPS growth | -20.1% | -10.0% | -6.2% | — |
| Free cash flow growth | -4.1% | +5.4% | -0.8% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · CH · as of 2026-03-31. Figures in CHF; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.